Transcutaneous Glucose Sensor with Modular Electronics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional blood glucose monitoring methods, such as self-monitoring blood glucose (SMBG), are uncomfortable and infrequent, leading to inadequate timely detection of hyperglycemic or hypoglycemic conditions in diabetic patients, hindering informed insulin therapy decisions.

Innovation Solution

A transcutaneous analyte sensor system with a sensor for insertion under the skin, a housing, and an electronics unit connected via a key mechanism, allowing for continuous glucose monitoring with calibration and data processing, and featuring a receiver for displaying sensor data and controlling sensor operation based on predetermined conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional self-monitoring blood glucose (SMBG) methods are used, then the measurement can be performed with simple equipment, but the monitoring frequency is insufficient and timely detection of glucose conditions is inadequate

Engineering Contradiction:
Improvemonitoring frequencyVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical finger-pricking SMBG method with a transcutaneous sensor system that uses electrochemical sensing to detect glucose levels continuously through the skin, eliminating the need for repeated manual blood sampling

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent implements continuous glucose monitoring through a transcutaneous sensor that provides uninterrupted measurement of glucose levels, replacing the discontinuous nature of conventional SMBG where measurements are taken only at specific time intervals

Inventive Principle:
Principle #20Continuity of useful action

2Measurement precision

If transcutaneous sensor is inserted for continuous monitoring, then frequent and accurate glucose data is obtained, but the device complexity and insertion procedure become more complex

Engineering Contradiction:
Improveglucose measurement accuracyVSAvoidsensor system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent divides the monitoring system into separate modular components: a transcutaneous sensor for glucose detection, an electronics unit for signal processing, and a receiver for data display, allowing each component to be optimized independently while reducing overall system complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an electronics unit as an intermediary between the transcutaneous sensor and the receiver, which processes and manages the complex signals from the sensor before transmitting them to the display device, thereby simplifying the overall system architecture

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If transcutaneous sensor is used for continuous monitoring, then timely detection of hyperglycemic or hypoglycemic conditions is improved, but the device requires more complex electronics and data processing

Engineering Contradiction:
Improvetimely detection reliabilityVSAvoidelectronics unit complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements automatic calibration and alert functions where the system self-adjusts and notifies users of glucose level changes without requiring manual intervention, reducing the complexity of user interaction despite sophisticated internal processing

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent incorporates feedback mechanisms where the receiver provides real-time information about glucose levels and trends to the user, enabling timely therapeutic decisions while the electronics unit continuously processes sensor data to maintain accurate monitoring

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20250107728A1Transcutaneous analyte sensor
Publication Date: 2025.04.03 DEXCOM INC
  • US20250107728A1 patent drawing
  • US20250107728A1 patent drawing
  • US20250107728A1 patent drawing

AI summary

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.